Published 6 days ago • loading... • Updated 6 days agoShow Less IconCommon Insulin Pen Faces Supply Issues Amid Rising Demand Summary by Wral NewsSanofi has confirmed intermittent supply issues affecting Lantus SoloStar insulin pens due to increased demand. Here's what patients should know if they're having trouble filling their prescriptions.Share menu2 Articles2 ArticlesAllLeftCenter2RightSearch IconSort IconWral NewsCenterFactualityOwnershipCommon insulin pen faces supply issues amid rising demandSanofi has confirmed intermittent supply issues affecting Lantus SoloStar insulin pens due to increased demand. Here's what patients should know if they're having trouble filling their prescriptions.6 days ago·Raleigh, United StatesRead Full ArticleSTATCenterFactualityOwnershipPopular insulin product enters shortage as other pens leave marketShort supply isn't official FDA shortage, but Sanofi says market is tight after Eli Lilly, Biocon Biologics, and Novo Nordisk ended insulin products.6 days ago·Boston, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources2Leaning Left0Leaning Right0Center2Last Updated6 days agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSTAT broke the news in Boston, United States 6 days ago on Thursday, July 23, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsEli Lilly Plus IconNovo Nordisk Plus IconUnited States Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsEli Lilly Plus IconNovo Nordisk Plus IconUnited States Plus IconShow All